Back to all studies
⚖️
Phase 3
Weight Loss
in-person
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteo…
Sponsored by Novo Nordisk A/S
Compensation
Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
Duration
3 months
Location
Nationwide
About this study
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and knee osteoarthritis. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing obesity
- • Able to attend in-person clinic visits
What's included
- • Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Research Study?
Explore clinical trials and paid research opportunities. Compensation varies by study and is never guaranteed.